Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cells in ischemic stroke
NCT01849887Phase 2Withdrawn
- Sponsor
- University of California, Irvine
- Start
- Jan 2016
- Primary completion
- Jan 2016
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow-derived mesenchymal stem cells in ischemic stroke, sponsored by University of California, Irvine. Planned start Jan 2016; status: withdrawn.
02
Drugs
bone marrow-derived mesenchymal stem cells
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01849887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849887.